We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
6
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Completed
4
66.7%
Terminated
1
16.7%
Unknown
No approval data available
- India's fragmented regulatory system, split between Central and State bodies, creates significant challenges for pharmaceutical companies seeking drug approvals and consistent oversight. - Critical shortage of skilled regulatory personnel and trained inspectors hampers effective monitoring and compliance of drug quality standards across the country. - Pharmaceutical companies face multiple regulatory challenges including delayed new drug approvals, inadequate data protection, and slow clinical trial authorization processes.
